Filing Flows › Comparisons › ENSG vs NHC
Ensign Group vs National Healthcare: ENSG and NHC compared
Ensign Group is the larger company: $1.5B of revenue in its latest quarter (Q3 2026) against $408M for National Healthcare (Q3 2026). Ensign Group is growing faster (+14% against +7% a year earlier). National Healthcare is more profitable, with an operating margin of 10.0% against 9.3%.
Where the money goes: ENSG and NHC
Ensign Group (ENSG) · Q3 2026
Ensign Group, Q3 2026: revenue $1.5B (+14% year over year), operating margin 9.3%, net earnings $104M, operating cash flow $240M. The chart follows the revenue to costs, profit and cash.
National Healthcare (NHC) · Q3 2026
National Healthcare, Q3 2026: revenue $408M (+7% year over year), operating margin 10.0%, net earnings $13.6M, operating cash flow $99.2M. The chart follows the revenue to costs, profit and cash.
| Ensign Group (ENSG) | National Healthcare (NHC) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.5B | $408M |
| Revenue growth, Y/Y | +14% | +7% |
| Operating margin | 9.3% | 10.0% |
| Net earnings | $104M | $13.6M |
| Net margin | 7.0% | 3.3% |
| Operating cash flow | $240M | $99.2M |
| Free cash flow | $193M | — |
| Market value | $10.7B | $3.3B |
| P/E | 26.8× | 28.7× |
| Analysts’ mean target | $225.80 | — |
Questions
Which is bigger, Ensign Group or National Healthcare?
Ensign Group is the larger company: $1.5B of revenue in its latest quarter (Q3 2026) against $408M for National Healthcare (Q3 2026).
Is Ensign Group or National Healthcare growing faster?
Ensign Group is growing faster (+14% against +7% a year earlier).
Which is more profitable, Ensign Group or National Healthcare?
National Healthcare is more profitable, with an operating margin of 10.0% against 9.3%.
More: Ensign Group earnings · how Ensign Group makes money · National Healthcare earnings · how National Healthcare makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 27, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.